Condition: PARKINSON DISEASE (Disorder) · Sponsor: Pusan National University Yangsan Hospital
This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about three sessions per week, once daily, 20 minutes per session) in patients with Parkinson's disease.
This description comes directly from the study's public registry record.
Jisoo Baik · 082+055-360-4159 · zisoo@pusan.ac.kr
Always discuss trial participation with your own doctor first.
| Pusan National University Yangsan Hospital | Yangsan, Gyeongsangnam-do, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07271927